{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:05:28Z","timestamp":1789826728381,"version":"4.0.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Psych"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s40501-019-0165-5","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T07:02:40Z","timestamp":1548831760000},"page":"17-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Use of Antipsychotic Drugs During Pregnancy"],"prefix":"10.1007","volume":"6","author":[{"given":"Hannah K.","family":"Betcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal T.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"2","key":"165_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.2082","volume":"20","author":"GC Alexander","year":"2011","unstructured":"Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf. 2011;20(2):177\u201384. \n                      https:\/\/doi.org\/10.1002\/pds.2082\n                      \n                    .","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"165_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00737-014-0465-0","volume":"17","author":"U Camsari","year":"2014","unstructured":"Camsari U, Viguera AC, Ralston L, Baldessarini RJ, Cohen LS. Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men. Arch Womens Ment Health. 2014;17(6):583\u20136. \n                      https:\/\/doi.org\/10.1007\/s00737-014-0465-0\n                      \n                    .","journal-title":"Arch Womens Ment Health"},{"issue":"10","key":"165_CR3","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.4088\/JCP.15m09863","volume":"76","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Antipsychotic treatment of adults in the United States. J Clin Psychiatry. 2015;76(10):1346\u201353. \n                      https:\/\/doi.org\/10.4088\/JCP.15m09863\n                      \n                    .","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"165_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","volume":"16","author":"S Toh","year":"2013","unstructured":"Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, et al. Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013;16(2):149\u201357. \n                      https:\/\/doi.org\/10.1007\/s00737-013-0330-6\n                      \n                    .","journal-title":"Arch Womens Ment Health"},{"issue":"11","key":"165_CR5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1176\/appi.ps.201600408","volume":"68","author":"Y Park","year":"2017","unstructured":"Park Y, Huybrechts KF, Cohen JM, Bateman BT, Desai RJ, Patorno E, et al. Antipsychotic medication use among publicly insured pregnant women in the United States. Psychiatr Serv. 2017;68(11):1112\u20139. \n                      https:\/\/doi.org\/10.1176\/appi.ps.201600408\n                      \n                    .","journal-title":"Psychiatr Serv"},{"issue":"3","key":"165_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","volume":"52","author":"PL Gilbert","year":"1995","unstructured":"Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Arch Gen Psychiatry. 1995;52(3):173\u201388.","journal-title":"Arch Gen Psychiatry"},{"key":"165_CR7","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","volume":"164","author":"AC Viguera","year":"2007","unstructured":"Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatr. 2007;164:1817\u201324.","journal-title":"Am J Psychiatr"},{"issue":"1","key":"165_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1176\/appi.ajp.162.1.79","volume":"162","author":"AV Jablensky","year":"2005","unstructured":"Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich L-A. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatr. 2005;162(1):79\u201391.","journal-title":"Am J Psychiatr"},{"issue":"1","key":"165_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.earlhumdev.2008.07.002","volume":"85","author":"MA Diego","year":"2009","unstructured":"Diego MA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, Gonzalez-Quintero VH. Prenatal depression restricts fetal growth. Early Hum Dev. 2009;85(1):65\u201370. \n                      https:\/\/doi.org\/10.1016\/j.earlhumdev.2008.07.002\n                      \n                    .","journal-title":"Early Hum Dev"},{"issue":"3","key":"165_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.infbeh.2006.03.003","volume":"29","author":"T Field","year":"2006","unstructured":"Field T, Diego M, Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: a review. Infant Behav Dev. 2006;29(3):445\u201355. \n                      https:\/\/doi.org\/10.1016\/j.infbeh.2006.03.003\n                      \n                    .","journal-title":"Infant Behav Dev"},{"issue":"10","key":"165_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/0895-4356(92)90149-H","volume":"45","author":"RA Steer","year":"1992","unstructured":"Steer RA, Scholl TO, Hediger ML, Fischer RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol. 1992;45(10):1093\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"165_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/14767050701209560","volume":"20","author":"J Alder","year":"2007","unstructured":"Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med. 2007;20(3):189\u2013209. \n                      https:\/\/doi.org\/10.1080\/14767050701209560\n                      \n                    .","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"165_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/1469-7610.00661","volume":"41","author":"C Martins","year":"2000","unstructured":"Martins C, Gaffan EA. Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. J Child Psychol Psychiatry. 2000;41(6):737\u201346.","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"165_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5539\/gjhs.v8n5p11","volume":"8","author":"R Vameghi","year":"2015","unstructured":"Vameghi R, Amir Ali Akbari S, Sajjadi H, Sajedi F, Alavimajd H. Correlation between mothers\u2019 depression and developmental delay in infants aged 6-18 months. Global J Health Sci. 2015;8(5):11\u20138. \n                      https:\/\/doi.org\/10.5539\/gjhs.v8n5p11\n                      \n                    .","journal-title":"Global J Health Sci"},{"issue":"5","key":"165_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3109\/09540261.2010.514600","volume":"22","author":"KL Leight","year":"2010","unstructured":"Leight KL, Fitelson EM, Weston CA, Wisner KL. Childbirth and mental disorders. Int Rev Psychiatry. 2010;22(5):453\u201371. \n                      https:\/\/doi.org\/10.3109\/09540261.2010.514600\n                      \n                    .","journal-title":"Int Rev Psychiatry"},{"key":"165_CR16","doi-asserted-by":"publisher","unstructured":"Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D et al. Saving mothers\u2019 lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG : an international journal of obstetrics and gynaecology. 2011;118 Suppl 1:1\u2013203. doi:\n                      https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02847.x\n                      \n                    .","DOI":"10.1111\/j.1471-0528.2010.02847.x"},{"key":"165_CR17","unstructured":"Centers for Disease C, Prevention. Update on overall prevalence of major birth defects\u2014Atlanta, Georgia, 1978\u20132005. MMWR Morb Mortal Wkly Rep. 2008;57(1):1\u20135."},{"key":"165_CR18","unstructured":"Bajaj L, Hambidge S, Nyquist A, Kerby G. Berman\u2019s pediatric decision making. 5th ed. Elsevier; 2011."},{"key":"165_CR19","unstructured":"Centers for Disease Control and Prevention. World Birth Defects Day. 2018. \n                      https:\/\/www.cdc.gov\/features\/birth-defects-day\n                      \n                    \/. Accessed 10\/18\/18 2018."},{"key":"165_CR20","unstructured":"FDA. Pregnancy and Lactation Labeling Final Rule. 2014. \n                      https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/Labeling\/ucm093307.htm\n                      \n                    . Accessed 5\/29\/15 2015."},{"issue":"9","key":"165_CR21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","volume":"73","author":"KF Huybrechts","year":"2016","unstructured":"\u2022 Huybrechts KF, Hernandez-Diaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA psychiatry. 2016;73(9):938\u201346. \n                      https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.1520\n                      \n                     Largest study to date examining the risk of congenital malformations after antipsychotic expsoure.","journal-title":"JAMA psychiatry"},{"issue":"5","key":"165_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1192\/bjp.bp.107.041541","volume":"192","author":"JJ Newham","year":"2008","unstructured":"Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry. 2008;192(5):333\u20137. \n                      https:\/\/doi.org\/10.1192\/bjp.bp.107.041541\n                      \n                    .","journal-title":"Br J Psychiatry"},{"issue":"2\u20133","key":"165_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.schres.2016.07.023","volume":"176","author":"I Petersen","year":"2016","unstructured":"Petersen I, Sammon CJ, McCrea RL, Osborn DPJ, Evans SJ, Cowen PJ, et al. Risks associated with antipsychotic treatment in pregnancy: comparative cohort studies based on electronic health records. Schizophr Res. 2016;176(2\u20133):349\u201356. \n                      https:\/\/doi.org\/10.1016\/j.schres.2016.07.023\n                      \n                    .","journal-title":"Schizophr Res"},{"issue":"1","key":"165_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.231.1.62","volume":"231","author":"FW McCullar","year":"1975","unstructured":"McCullar FW, Heggeness L. Limb malformations following maternal use of haloperidol. JAMA. 1975;231(1):62\u20134.","journal-title":"JAMA"},{"key":"165_CR25","first-page":"85","volume":"18","author":"P Dieulangard","year":"1966","unstructured":"Dieulangard P. Sur un cas d\u2019ectro-phocomelie peutetre d'origine medicamenteuse. Gynecol Obstet. 1966;18:85\u20137.","journal-title":"Gynecol Obstet"},{"key":"165_CR26","unstructured":"Briggs G, Freeman R, Jaffe S. Drugs in pregnancy and lactation 9th edition. 9th ed.: Lippincott Williams & Wilkins; 2011."},{"issue":"4","key":"165_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/009127006900900403","volume":"9","author":"A Waes","year":"1969","unstructured":"Waes A, Velde E. Safety evaluation of haloperidol in the treatment of hyperemesis Gravidarum. J Clin Pharmacol and J New Drugs. 1969;9(4):224\u20137. \n                      https:\/\/doi.org\/10.1177\/009127006900900403\n                      \n                    .","journal-title":"J Clin Pharmacol and J New Drugs"},{"issue":"3","key":"165_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","volume":"28","author":"M Reis","year":"2008","unstructured":"Reis M, Kallen B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28(3):279\u201388. \n                      https:\/\/doi.org\/10.1097\/JCP.0b013e318172b8d5\n                      \n                    .","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"165_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4088\/JCP.v66n0307","volume":"66","author":"O Diav-Citrin","year":"2005","unstructured":"Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry. 2005;66(3):317\u201322.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"165_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","volume":"116","author":"HC Lin","year":"2010","unstructured":"Lin HC, Chen IJ, Chen YH, Lee HC, Wu FJ. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res. 2010;116(1):55\u201360. \n                      https:\/\/doi.org\/10.1016\/j.schres.2009.10.011\n                      \n                    .","journal-title":"Schizophr Res"},{"issue":"5","key":"165_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/0002-9378(77)90029-1","volume":"128","author":"D Slone","year":"1977","unstructured":"Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol. 1977;128(5):486\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"165_CR32","volume-title":"Birth defects and drugs in pregnancy","author":"O Heinonen","year":"1977","unstructured":"Heinonen O, Sloan D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, Massachusetts: Publishing Sciences Group Inc; 1977."},{"key":"165_CR33","doi-asserted-by":"publisher","unstructured":"\u2022 Cohen LS, Viguera AC, McInerney KA, Freeman MP, Sosinsky AZ, Moustafa D, Marfurt SP et al. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry 2016;173(3):263\u201370. \n                      https:\/\/doi.org\/10.1176\/appi.ajp.2015.15040506\n                      \n                    . Comprehensive evaluation of quetiapine expsoure in pregnancy.","DOI":"10.1176\/appi.ajp.2015.15040506"},{"issue":"4","key":"165_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","volume":"33","author":"F Habermann","year":"2013","unstructured":"Habermann F, Fritzsche J, Fuhlbruck F, Wacker E, Allignol A, Weber-Schoendorfer C, et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013;33(4):453\u201362. \n                      https:\/\/doi.org\/10.1097\/JCP.0b013e318295fe12\n                      \n                    .","journal-title":"J Clin Psychopharmacol"},{"key":"165_CR35","doi-asserted-by":"publisher","unstructured":"Sadowski A, Todorow M, Yazdani Brojeni P, Koren G, Nulman I. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open. 2013, 3(7). \n                      https:\/\/doi.org\/10.1136\/bmjopen-2013-003062\n                      \n                    .","DOI":"10.1136\/bmjopen-2013-003062"},{"issue":"7","key":"165_CR36","doi-asserted-by":"publisher","first-page":"e0132280","DOI":"10.1371\/journal.pone.0132280","volume":"10","author":"MJ Sorensen","year":"2015","unstructured":"Sorensen MJ, Kjaersgaard MI, Pedersen HS, Vestergaard M, Christensen J, Olsen J, et al. Risk of fetal death after treatment with antipsychotic medications during pregnancy. PLoS One. 2015;10(7):e0132280. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0132280\n                      \n                    .","journal-title":"PLoS One"},{"issue":"4","key":"165_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/pds.3749","volume":"24","author":"F Bellet","year":"2015","unstructured":"\u2022 Bellet F, Beyens MN, Bernard N, Beghin D, Elefant E, Vial T. Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study. Pharmacoepidemiol Drug Saf. 2015;24(4):368\u201380. \n                      https:\/\/doi.org\/10.1002\/pds.3749\n                      \n                     Study of the use of aripiprazole in pregnancy and pregnancy and birth related outcomes.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"165_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s40264-016-0413-1","volume":"39","author":"F Montastruc","year":"2016","unstructured":"Montastruc F, Salvo F, Arnaud M, Begaud B, Pariente A. Signal of gastrointestinal congenital malformations with antipsychotics after minimising competition bias: a disproportionality analysis using data from Vigibase((R)). Drug Saf. 2016;39(7):689\u201396. \n                      https:\/\/doi.org\/10.1007\/s40264-016-0413-1\n                      \n                    .","journal-title":"Drug Saf"},{"key":"165_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jad.2018.06.004","volume":"238","author":"M Galbally","year":"2018","unstructured":"\u2022 Galbally M, Frayne J, Watson SJ, Snellen M. Aripiprazole and pregnancy: a retrospective, multicentre study. J Affect Disord. 2018;238:593\u20136. \n                      https:\/\/doi.org\/10.1016\/j.jad.2018.06.004\n                      \n                     Study of the use of aripiprazole in pregnancy and pregnancy and birth related outcomes.","journal-title":"J Affect Disord"},{"issue":"3","key":"165_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2165\/00002018-200730030-00006","volume":"30","author":"D Coppola","year":"2007","unstructured":"Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf. 2007;30(3):247\u201364.","journal-title":"Drug Saf"},{"issue":"4","key":"165_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bcpt.12372","volume":"116","author":"ZN Ennis","year":"2015","unstructured":"Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol. 2015;116(4):315\u201320. \n                      https:\/\/doi.org\/10.1111\/bcpt.12372\n                      \n                    .","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"165_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00737-014-0496-6","volume":"18","author":"AK Ozdemir","year":"2015","unstructured":"Ozdemir AK, Pak SC, Canan F, Gecici O, Kuloglu M, Gucer MK. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Arch Womens Ment Health. 2015;18(5):739\u201340. \n                      https:\/\/doi.org\/10.1007\/s00737-014-0496-6\n                      \n                    .","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"165_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-0042-110492","volume":"50","author":"FJ Zamora Rodriguez","year":"2017","unstructured":"Zamora Rodriguez FJ, Benitez Vega C, Sanchez-Waisen Hernandez MR, Guisado Macias JA, Vaz Leal FJ. Use of paliperidone palmitate throughout a schizoaffective disorder patient\u2019s gestation period. Pharmacopsychiatry. 2017;50(1):38\u201340. \n                      https:\/\/doi.org\/10.1055\/s-0042-110492\n                      \n                    .","journal-title":"Pharmacopsychiatry"},{"key":"165_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00737-018-0828-z","volume":"21","author":"M Onken","year":"2018","unstructured":"Onken M, Mick I, Schaefer C. Paliperidone and pregnancy\u2014an evaluation of the German Embryotox database. Arch Womens Ment Health. 2018;21:657\u201362. \n                      https:\/\/doi.org\/10.1007\/s00737-018-0828-z\n                      \n                    .","journal-title":"Arch Womens Ment Health"},{"key":"165_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/2050-6511-14-38","volume":"14","author":"E Brunner","year":"2013","unstructured":"Brunner E, Falk DM, Jones M, Dey DK, Shatapathy CC. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. BMC Pharmacol Toxicol. 2013;14:38. \n                      https:\/\/doi.org\/10.1186\/2050-6511-14-38\n                      \n                    .","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3","key":"165_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/JCP.0b013e3181db8734","volume":"30","author":"GN Babu","year":"2010","unstructured":"Babu GN, Desai G, Tippeswamy H, Chandra PS. Birth weight and use of olanzapine in pregnancy: a prospective comparative study. J Clin Psychopharmacol. 2010;30(3):331\u20132. \n                      https:\/\/doi.org\/10.1097\/JCP.0b013e3181db8734\n                      \n                    .","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"165_CR47","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archgenpsychiatry.2011.1870","volume":"69","author":"R Boden","year":"2012","unstructured":"Boden R, Lundgren M, Brandt L, Reutfors J, Kieler H. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry. 2012;69(7):715\u201321. \n                      https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.1870\n                      \n                    .","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"165_CR48","doi-asserted-by":"publisher","first-page":"1,478","DOI":"10.4088\/JCP.v66n0406","volume":"66","author":"K McKenna","year":"2005","unstructured":"McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66(4):1,478\u201349.","journal-title":"J Clin Psychiatry"},{"key":"165_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajp.2016.04.009","volume":"22","author":"VS Sreeraj","year":"2016","unstructured":"Sreeraj VS, Venkatasubramanian G. Safety of clozapine in a woman with triplet pregnancy: a case report. Asian J Psychiatr. 2016;22:67\u20138. \n                      https:\/\/doi.org\/10.1016\/j.ajp.2016.04.009\n                      \n                    .","journal-title":"Asian J Psychiatr"},{"issue":"3","key":"165_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0020-7292(02)00276-X","volume":"79","author":"Y Yogev","year":"2002","unstructured":"Yogev Y, Ben-Haroush A, Kaplan B. Maternal clozapine treatment and decreased fetal heart rate variability. Int J Gynaecol Obstet. 2002;79(3):259\u201360.","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"165_CR51","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4088\/JCP.v58n0806f","volume":"58","author":"SC Stoner","year":"1997","unstructured":"Stoner SC, Sommi RW Jr, Marken PA, Anya I, Vaughn J. Clozapine use in two full-term pregnancies. J Clin Psychiatry. 1997;58(8):364\u20135.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"165_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0924-9338(96)88396-9","volume":"11","author":"V Michele Di","year":"1996","unstructured":"Di Michele V, Ramenghi L, Sabatino G. Clozapine and lorazepam administration in pregnancy. Eur Psychiatry. 1996;11(4):214. \n                      https:\/\/doi.org\/10.1016\/0924-9338(96)88396-9\n                      \n                    .","journal-title":"Eur Psychiatry"},{"key":"165_CR53","first-page":"197","volume":"6","author":"V Dev","year":"1995","unstructured":"Dev V, Krupp P. Adverse event profile and safety of clozapine. Rev Contem Pharmacoth. 1995;6:197\u2013208.","journal-title":"Rev Contem Pharmacoth"},{"issue":"1","key":"165_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0269881107079171","volume":"22","author":"A Duran","year":"2008","unstructured":"Duran A, Ugur MM, Turan S, Emul M. Clozapine use in two women with schizophrenia during pregnancy. J Psychopharmacol. 2008;22(1):111\u20133. \n                      https:\/\/doi.org\/10.1177\/0269881107079171\n                      \n                    .","journal-title":"J Psychopharmacol"},{"issue":"12","key":"165_CR55","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/070674370404901213","volume":"49","author":"N Gupta","year":"2004","unstructured":"Gupta N, Grover S. Safety of clozapine in 2 successive pregnancies. Can J Psychiatr. 2004;49(12):863.","journal-title":"Can J Psychiatr"},{"issue":"1","key":"165_CR56","first-page":"168","volume":"150","author":"MD Waldman","year":"1993","unstructured":"Waldman MD, Safferman AZ. Pregnancy and clozapine. Am J Psychiatry. 1993;150(1):168\u20139.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"165_CR57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4103\/0019-5545.31586","volume":"48","author":"S Sethi","year":"2006","unstructured":"Sethi S. Clozapine in pregnancy. Indian J Psychiatry. 2006;48(3):196\u20137. \n                      https:\/\/doi.org\/10.4103\/0019-5545.31586\n                      \n                    .","journal-title":"Indian J Psychiatry"},{"issue":"6","key":"165_CR58","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1176\/ajp.151.6.945","volume":"151","author":"C Barnas","year":"1994","unstructured":"Barnas C, Bergant A, Hummer M, Saria A, Fleischhacker WW. Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry. 1994;151(6):945. \n                      https:\/\/doi.org\/10.1176\/ajp.151.6.945\n                      \n                    .","journal-title":"Am J Psychiatry"},{"issue":"8","key":"165_CR59","first-page":"489","volume":"36","author":"MP Cruz","year":"2011","unstructured":"Cruz MP. Lurasidone HCl (Latuda), an Oral, once-daily atypical antipsychotic agent for the treatment of patients with schizophrenia. P T. 2011;36(8):489\u201392.","journal-title":"P T"},{"issue":"6","key":"165_CR60","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0892-0362(92)90050-K","volume":"14","author":"JG Auerbach","year":"1992","unstructured":"Auerbach JG, Hans SL, Marcus J, Maeir S. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol. 1992;14(6):399\u2013406.","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"165_CR61","doi-asserted-by":"publisher","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","volume":"9","author":"J Kulkarni","year":"2014","unstructured":"Kulkarni J, Worsley R, Gilbert H, Gavrilidis E, Van Rheenen TE, Wang W, et al. A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies. PLoS One. 2014;9(5):e94788.","journal-title":"PLoS One"},{"issue":"5","key":"165_CR62","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/ajo.12621","volume":"57","author":"J Frayne","year":"2017","unstructured":"Frayne J, Nguyen T, Bennett K, Allen S, Hauck Y, Liira H. The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness. Aust N Z J Obstet Gynaecol. 2017;57(5):526\u201332. \n                      https:\/\/doi.org\/10.1111\/ajo.12621\n                      \n                    .","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"165_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","volume":"69","author":"KC Johnson","year":"2012","unstructured":"Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69(8):787\u201394. \n                      https:\/\/doi.org\/10.1001\/archgenpsychiatry.2012.160\n                      \n                    .","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"165_CR64","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00213-013-3060-6","volume":"228","author":"M Peng","year":"2013","unstructured":"Peng M, Gao K, Ding Y, Ou J, Calabrese JR, Wu R, et al. Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology. 2013;228(4):577\u201384.","journal-title":"Psychopharmacology"},{"issue":"5","key":"165_CR65","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/fcp.12209","volume":"30","author":"C Hurault-Delarue","year":"2016","unstructured":"Hurault-Delarue C, Damase-Michel C, Finotto L, Guitard C, Vayssiere C, Montastruc JL, et al. Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database. Fundam Clin Pharmacol. 2016;30(5):476\u201382. \n                      https:\/\/doi.org\/10.1111\/fcp.12209\n                      \n                    .","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"165_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123373","volume":"10","author":"P Shao","year":"2015","unstructured":"Shao P, Ou J, Peng M, Zhao J, Chen J, Wu R. Effects of clozapine and other atypical antipsychotics on infants development who were exposed to as fetus: a post-hoc analysis. PLoS One. 2015;10(4):e0123373. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0123373\n                      \n                    .","journal-title":"PLoS One"},{"issue":"2","key":"165_CR67","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/acps.12754","volume":"136","author":"MA Wibroe","year":"2017","unstructured":"Wibroe MA, Mathiasen R, Pagsberg AK, Uldall P. Risk of impaired cognition after prenatal exposure to psychotropic drugs. Acta Psychiatr Scand. 2017;136(2):177\u201387. \n                      https:\/\/doi.org\/10.1111\/acps.12754\n                      \n                    .","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"165_CR68","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/0091217417696739","volume":"51","author":"S Hatters Friedman","year":"2016","unstructured":"\u2022 Hatters Friedman S, Moller-Olsen C, Prakash C, North A. Atypical antipsychotic use and outcomes in an urban maternal mental health service. Int J Psychiatry Med. 2016;51(6):521\u201333. \n                      https:\/\/doi.org\/10.1177\/0091217417696739\n                      \n                     Evaluation of atypical antipsychotic use and pregnancy and birth outcomes.","journal-title":"Int J Psychiatry Med"},{"issue":"6","key":"165_CR69","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1176\/appi.ajp.2018.17040393","volume":"175","author":"Y Park","year":"2018","unstructured":"\u2022 Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, et al. Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. Am J Psychiatry. 2018;175(6):564\u201374. \n                      https:\/\/doi.org\/10.1176\/appi.ajp.2018.17040393\n                      \n                     Evaluation of atypical antipsychotic use and gestational diabetes.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"165_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ogc.2018.05.002","volume":"45","author":"CT Clark","year":"2018","unstructured":"Clark CT, Wisner KL. Treatment of Peripartum bipolar disorder. Obstet Gynecol Clin N Am. 2018;45(3):403\u201317. \n                      https:\/\/doi.org\/10.1016\/j.ogc.2018.05.002\n                      \n                    .","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"3","key":"165_CR71","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/cpt.770","volume":"103","author":"AA Westin","year":"2018","unstructured":"Westin AA, Brekke M, Molden E, Skogvoll E, Castberg I, Spigset O. Treatment with antipsychotics in pregnancy: changes in drug disposition. Clin Pharmacol Ther. 2018;103(3):477\u201384. \n                      https:\/\/doi.org\/10.1002\/cpt.770\n                      \n                    .","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"165_CR72","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","volume":"44","author":"GD Anderson","year":"2005","unstructured":"Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet. 2005;44(10):989\u20131008. \n                      https:\/\/doi.org\/10.2165\/00003088-200544100-00001\n                      \n                    .","journal-title":"Clin Pharmacokinet"},{"key":"165_CR73","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.schres.2017.09.043","volume":"195","author":"M Paulzen","year":"2018","unstructured":"Paulzen M, Goecke TW, Kuzin M, Augustin M, Grunder G, Schoretsanitis G. Pregnancy exposure to quetiapine\u2014therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes. Schizophr Res. 2018;195:252\u20137. \n                      https:\/\/doi.org\/10.1016\/j.schres.2017.09.043\n                      \n                    .","journal-title":"Schizophr Res"},{"issue":"3","key":"165_CR74","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JCP.0000000000000491","volume":"36","author":"F Uguz","year":"2016","unstructured":"Uguz F. Second-generation antipsychotics during the lactation period: a comparative systematic review on infant safety. J Clin Psychopharmacol. 2016;36(3):244\u201352. \n                      https:\/\/doi.org\/10.1097\/JCP.0000000000000491\n                      \n                    .","journal-title":"J Clin Psychopharmacol"},{"key":"165_CR75","unstructured":"Risperidone. Drugs and Lactation Database (LactMed). Bethesda (MD)2006."},{"key":"165_CR76","unstructured":"Lurasidone. Drugs and Lactation Database (LactMed). Bethesda (MD)2006."},{"issue":"5","key":"165_CR77","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/0269881117699361","volume":"31","author":"RH McAllister-Williams","year":"2017","unstructured":"McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, et al. British association for psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol. 2017;31(5):519\u201352. \n                      https:\/\/doi.org\/10.1177\/0269881117699361\n                      \n                    .","journal-title":"J Psychopharmacol"},{"issue":"10","key":"165_CR78","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.euroneuro.2016.08.008","volume":"26","author":"I Pacchiarotti","year":"2016","unstructured":"Pacchiarotti I, Leon-Caballero J, Murru A, Verdolini N, Furio MA, Pancheri C, et al. Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder. Eur Neuropsychopharmacol. 2016;26(10):1562\u201378. \n                      https:\/\/doi.org\/10.1016\/j.euroneuro.2016.08.008\n                      \n                    .","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"165_CR79","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/15622975.2015.1009163","volume":"16","author":"A Hasan","year":"2015","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry. 2015;16(3):142\u201370. \n                      https:\/\/doi.org\/10.3109\/15622975.2015.1009163\n                      \n                    .","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"165_CR80","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1176\/jnp.2007.19.2.196","volume":"19","author":"DN Mendhekar","year":"2007","unstructured":"Mendhekar DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J Neuropsychiatr Clin Neurosci. 2007;19(2):196\u20137. \n                      https:\/\/doi.org\/10.1176\/jnp.2007.19.2.196\n                      \n                    .","journal-title":"J Neuropsychiatr Clin Neurosci"}],"container-title":["Current Treatment Options in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40501-019-0165-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-019-0165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-019-0165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:21:54Z","timestamp":1580343714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40501-019-0165-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1007\/s40501-019-0165-5","relation":{},"ISSN":["2196-3061"],"issn-type":[{"value":"2196-3061","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"30 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Clark reports grants from NICHD-K23 grant, during the conduct of the study, and Miller Medical Communications as a speaker for CME activities on postpartum depression.Hannah K. Betcher and Catalina Montiel declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}